| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EMR | Common Stock | Award | +7,221 | +9.6% | 82,304 | 01 Nov 2021 | Direct | F1, F2 | ||
| transaction | EMR | Common Stock | Award | +10,000 | +12% | 92,304 | 01 Nov 2021 | Direct | F3, F4 | ||
| holding | EMR | Common Stock | 4,238 | 01 Nov 2021 | 401(k) plan | ||||||
| holding | EMR | Common Stock | 1,903 | 01 Nov 2021 | 401(k) excess plan |
| Id | Content |
|---|---|
| F1 | Acquisition of 7,221 shares pursuant to Rule 16b-3 upon payout of 13,130 earned units under a performance share award under a shareholder-approved benefit plan. The payout was based on the level of achievement of financial targets for the performance period ended September 30, 2021. Of these 13,130 units, 7,221 units were paid in shares of Issuer stock, with the remaining 5,909 units paid in cash to cover the reporting person's tax obligations. |
| F2 | Price is not applicable to the acquisitions described in Note 1. |
| F3 | Grant of restricted stock under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d). |
| F4 | Price is not applicable to acquisitions resulting from grants of restricted stock. |